India’s Drug Regulatory Apparatus Set For ‘Big Ticket’ Changes

Also Looks Inward To Improve

India’s drugs regulator sets out plans for extensive digitization across the regulatory value chain and regulatory rationalization initiatives, while also “looking inward” to up its game as it tightens processes and enforcement. Audit action under the revised GMP norms is also being kicked off.

L-R: Nilesh Gupta, Managing Director, Lupin; Dr Rajeev Raghuvanshi, Drugs Controller General of India and Dr Arunish Chawla, Secretary, Department of Pharmaceuticals • Source: IPA

India’s drugs regulator expects to implement a raft of initiatives, including some “big ticket” items in the pipeline, as part of efforts to improve systems, processes and oversight, while also “looking inward” to up efficiencies and run a tight ship.

Key Takeaways

  • Digital drug regulatory system, rationalization efforts being initiated in India.

Addressing the Global Pharmaceutical Quality Summit in Mumbai, Dr Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), outlined plans for...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from India

More from Asia